| pubmed-article:20065860 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20065860 | lifeskim:mentions | umls-concept:C0376358 | lld:lifeskim |
| pubmed-article:20065860 | lifeskim:mentions | umls-concept:C0005558 | lld:lifeskim |
| pubmed-article:20065860 | lifeskim:mentions | umls-concept:C0034897 | lld:lifeskim |
| pubmed-article:20065860 | lifeskim:mentions | umls-concept:C0205276 | lld:lifeskim |
| pubmed-article:20065860 | lifeskim:mentions | umls-concept:C0024488 | lld:lifeskim |
| pubmed-article:20065860 | lifeskim:mentions | umls-concept:C0563532 | lld:lifeskim |
| pubmed-article:20065860 | lifeskim:mentions | umls-concept:C1517033 | lld:lifeskim |
| pubmed-article:20065860 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:20065860 | pubmed:dateCreated | 2010-2-22 | lld:pubmed |
| pubmed-article:20065860 | pubmed:abstractText | The objective of this study was to assess the feasibility of the combination of magnetic resonance (MR)-guided biopsy (MRGB) and diagnostic 3T MR imaging in the localization of local recurrence of prostate cancer (PCa) after external beam radiation therapy (EBRT). | lld:pubmed |
| pubmed-article:20065860 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20065860 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20065860 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20065860 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20065860 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20065860 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20065860 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20065860 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20065860 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:20065860 | pubmed:issn | 1536-0210 | lld:pubmed |
| pubmed-article:20065860 | pubmed:author | pubmed-author:WitjesJ... | lld:pubmed |
| pubmed-article:20065860 | pubmed:author | pubmed-author:BarentszJelle... | lld:pubmed |
| pubmed-article:20065860 | pubmed:author | pubmed-author:Hulsbergen-va... | lld:pubmed |
| pubmed-article:20065860 | pubmed:author | pubmed-author:VergunstHenkH | lld:pubmed |
| pubmed-article:20065860 | pubmed:author | pubmed-author:FüttererJurge... | lld:pubmed |
| pubmed-article:20065860 | pubmed:author | pubmed-author:HuismanHenkja... | lld:pubmed |
| pubmed-article:20065860 | pubmed:author | pubmed-author:HambrockThoma... | lld:pubmed |
| pubmed-article:20065860 | pubmed:author | pubmed-author:YakarDeryaD | lld:pubmed |
| pubmed-article:20065860 | pubmed:author | pubmed-author:van... | lld:pubmed |
| pubmed-article:20065860 | pubmed:author | pubmed-author:HoeksCaroline... | lld:pubmed |
| pubmed-article:20065860 | pubmed:author | pubmed-author:van LinEmileE | lld:pubmed |
| pubmed-article:20065860 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20065860 | pubmed:volume | 45 | lld:pubmed |
| pubmed-article:20065860 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20065860 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20065860 | pubmed:pagination | 121-5 | lld:pubmed |
| pubmed-article:20065860 | pubmed:meshHeading | pubmed-meshheading:20065860... | lld:pubmed |
| pubmed-article:20065860 | pubmed:meshHeading | pubmed-meshheading:20065860... | lld:pubmed |
| pubmed-article:20065860 | pubmed:meshHeading | pubmed-meshheading:20065860... | lld:pubmed |
| pubmed-article:20065860 | pubmed:meshHeading | pubmed-meshheading:20065860... | lld:pubmed |
| pubmed-article:20065860 | pubmed:meshHeading | pubmed-meshheading:20065860... | lld:pubmed |
| pubmed-article:20065860 | pubmed:meshHeading | pubmed-meshheading:20065860... | lld:pubmed |
| pubmed-article:20065860 | pubmed:meshHeading | pubmed-meshheading:20065860... | lld:pubmed |
| pubmed-article:20065860 | pubmed:meshHeading | pubmed-meshheading:20065860... | lld:pubmed |
| pubmed-article:20065860 | pubmed:meshHeading | pubmed-meshheading:20065860... | lld:pubmed |
| pubmed-article:20065860 | pubmed:meshHeading | pubmed-meshheading:20065860... | lld:pubmed |
| pubmed-article:20065860 | pubmed:meshHeading | pubmed-meshheading:20065860... | lld:pubmed |
| pubmed-article:20065860 | pubmed:meshHeading | pubmed-meshheading:20065860... | lld:pubmed |
| pubmed-article:20065860 | pubmed:meshHeading | pubmed-meshheading:20065860... | lld:pubmed |
| pubmed-article:20065860 | pubmed:meshHeading | pubmed-meshheading:20065860... | lld:pubmed |
| pubmed-article:20065860 | pubmed:meshHeading | pubmed-meshheading:20065860... | lld:pubmed |
| pubmed-article:20065860 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20065860 | pubmed:articleTitle | Feasibility of 3T dynamic contrast-enhanced magnetic resonance-guided biopsy in localizing local recurrence of prostate cancer after external beam radiation therapy. | lld:pubmed |
| pubmed-article:20065860 | pubmed:affiliation | Department of Radiology, Nijmegen Medical Centre, Radboud University, Nijmegen, The Netherlands. D.Yakar@rad.umcn.nl | lld:pubmed |
| pubmed-article:20065860 | pubmed:publicationType | Journal Article | lld:pubmed |
